InvestorsHub Logo

imanjen13

02/08/23 11:30 AM

#377465 RE: Pharma Sleuth #377459

If Elite restarts the trials for SequestOx, the stock price would soar as the upside for increased revenue is ginormous.
That being said, unless the uncertainty of the future revenue stream is achieved, I doubt the company would undertake the $3M test expense at this time. But.....you don't know what you don't know. Perhaps NH will have something to say on that subject which he kinda hinted at the last conference call.